May 25th, 2021: Opioids Are the Next Tobacco. Are Antibiotics the Next Opioids?
In our most recent Carrier Management article, Praedicat’s Senior Scientist and VP of Modeling, Dr. Adam Grossman and Quantitative Developer, Adam Feinman, consider this very intriguing question.
The meat production and agricultural industries could very well join drug makers and even grocery stores and restaurants in a long line of possible defendants in lawsuits alleging the presence of antimicrobial-resistant (AMR) bacteria in the food supply. So just because you are not writing a drug company doesn’t necessarily insulate you from drug-related litigation!
In this article, we review the possible avenues of AMR litigation and estimate costs, which could be as high as $120 billion should lawsuits come from state attorneys general, mirroring the path of opioid litigation.
Read the full article here.
Learn more about Praedicat’s PFAS Scenarios, the helpful Emerging Risk Scenario Platform, and our Emerging Risk Framework.
Have Questions?
Learn more about Praedicat and our Lloyd’s liability scenario solution, emerging risk framework, COVID-19 offerings, as well as our collaboration with AON Reinsurance Solutions.
Want to learn more about how you can get started? Contact a member of our client management team or sign up here to receive updates about Praedicat insights.